ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

ASRO President Tells Colleagues To Take Charge

October 26, 1990

In Brief: Jensen, Selikoff Receive ACS National Awards; CCIRC Schedules Mini-Symposium

October 22, 1976

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

Congress Passes NIH Reauthorization.

December 15, 2006

Risk Assessment Key In Long-Term Treatment

August 29, 2008

To Improve Clinical Trials Participation, Groups Plan An Awareness Campaign.

October 13, 2000